CSIMarket Company Name, Ticker, Industry, else..


Steris Plc  (NYSE: STE)
Other Ticker:  
 


 

Steris Plc

STE's Financial Statements and Analysis



Steris Plc reported in the third quarter of 2025 net earnings per share of $1.75 an increase by 23.24 % year on year from $1.42 and an improvement of 15.89 % from $1.51 realized in II. Quarter (Sep 30 2024).


third quarter of 2025
Earnings Per Share Revenues
$ 1.75 $  1,371 Mill
$+0.33     +23.24 % $-25M     -1.8 %



Steris Plc's Revenue fell by -1.8 % in third quarter of 2025 (Dec 31 2024) year on year, to $1,371 million and advanced by 3.13 % sequentially.


Steris Plc is Expected to report next financial results on May 15, 2025.

More on STE's Income Statement



Steris Plc 's net income of $173.285 million in the third quarter of 2025 increased by 22.95 % from net earnings of $140.945 million achieved in III. Quarter a year ago.

Sequentially net earnings grew by 14.63 % from net income of $151.173 million realized in previous quarter.

More on STE's Growth

Steris Plc Inventories
Inventories declined by -24.08 % to $649.56 million from III. Quarter a year ago, sequentially inventories fell by -5.72 %. In Dec 31 2024 company's net cash and cash equivalents decreased by $-17 million, capital expenditures grew by -118.936-24.98%, to $-89 millions compare to same quarter a year ago

More on STE's Cash flow Statement


Steris Plc payed out dividend of $2.18 per share in last 52 weeks representing 46.28 % of net earning per share in trailing twelve-month period.

During the same period Steris Plc earned $ 11.52 cash per share, on a free-cash flow basis 244.54 % of net earning per share.

Book value fell by -2.56 % sequentially to $64.83 per share.
Tangible Book value grew to $ 4.65 per share from $ 4.58.

Company repurchased 0.20 million shares or 0.20 % in Dec 31 2024.
Interest Coverage Ratio was 12.87. Debt Coverage Ratio was 0.35.

• More on STE's Dividends

 Market Capitalization (Millions) 23,115
 Shares Outstanding (Millions) 99
 Total Debt (Millions $) 2,164
 Revenue (TTM) (Millions $) 5,398
 Net Income (TTM) (Millions $) 469
 Cash Flow (TTM) (Millions $) -40
 Capital Exp. (TTM) (Millions $) -391
 Dividend TTM ($) 2.18 $
 Dividend Yield TTM (%) 0.98 %
 Employees (TTM) $ 18,000




Steris Plc payed out dividend of $2.18 per share in the last 52 weeks representing 46.28 % of net earning per share in trailing twelve-month period.

During the same period Steris Plc had $ 11.52 cash flow per share, on a free-cash flow basis 244.54 % of net earning per share.

Book value fell by -2.56 % sequentially to $64.83 per share.
Tangible Book value grew to $ 4.65 per share from $ 4.58.

Company repurchased 0.20 million shares or 0.20 % in Dec 31 2024.
Interest Coverage Ratio was 12.87. Debt Coverage Ratio was 0.35.

• More on STE's Balance Sheets

 Market Capitalization (Millions) 23,115
 Shares Outstanding (Millions) 99
 Total Debt (Millions $) 2,164
 Revenue (TTM) (Millions $) 5,398
 Net Income (TTM) (Millions $) 469
 Cash Flow (TTM) (Millions $) -40
 Capital Exp. (TTM) (Millions $) -391
 Dividend TTM ($) 2.18 $
 Dividend Yield TTM (%) 0.98 %
 Employees (TTM) $ 18,000
   


  News about Steris Plc Earnings

Steris Plc's Strong Financial Performance Sees Double-Digit Revenue Growth in Q3 2024

Steris Plc Reports Strong Financial Results in Q3 2024
Steris Plc, a leading company in the Medical Equipment and Supplies industry, has announced its financial results for the third quarter of 2024. The company reported revenue of $1.40 billion and earnings per share of $1.42. These results indicate a significant year-on-year growth, with revenue increasing by 14.774% and net profit per share growing by 14.52%.
In comparison to its industry peers, Steris Plc's top-line growth outperformed most other companies in the Medical Equipment and Supplies sector during the same reporting period. While the top-line for the two third-party companies in the sector advanced by only 3.13% from the previous year,...

Steris Plc Surpasses Medical Equipment Peers with Astounding 11% Revenue Surge in Q1 2024

The stock market has been abuzz with positive news lately, and Steris Plc (STE) is no exception. In the first quarter of 2024, the company posted impressive revenue figures of $1.28 billion, representing an increase of 11.072% compared to the previous year. Additionally, earnings per share (EPS) grew by a remarkable 13.64%, reaching $1.25. These numbers showcase the tremendous growth and prosperity that Steris Plc has been experiencing.
What sets Steris Plc apart from its peers in the Medical Equipment and Supplies sector is its unmatched revenue advancement. While the sector's average revenue elevation stood at 4.18% in the first quarter of 2024, Steris Plc far exceeded this figure with its 11.072% grow...

Despite Record Revenue Surge, Steris Plc Falls into Loss in Q4 2023

Steris Plc, a leading biotechnology and pharmaceuticals company, has announced a significant increase in revenue for the most recent fiscal period. The company reported a year-on-year revenue rise of 311.172% to $2.94 billion, which is an impressive figure. However, the company slipped into a net loss of $-0.60. This news is significant and has caused some concern among investors and stakeholders.
Compared to the preceding quarter, the income per share fell from $0.56 per share. On the other hand, revenue doubled by a substantial 322.827% from $696.24 million. In the fourth quarter of 2023, Steris Plc posted a net loss of $-90.386 million, as opposed to the net proceeds of $73.623 million recorded in the...


Date modified: 2025-02-11T04:58:57+00:00





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com